Edge Capital Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Edge Capital Group's BMY Position: Q4 2023 in Review
Edge Capital Group sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 3,958 shares — an estimated $230K sold.
Edge Capital Group first reported a position in BMY in Q4 2018 and held it in 19 quarters. The position peaked at $1.55M in Q1 2023. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.
- Edge Capital Group reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
- Edge Capital Group sold 3,958 Bristol-Myers Squibb shares in Q4 2023, an estimated $230K.
- Edge Capital Group first reported a position in Bristol-Myers Squibb in Q4 2018 and held it in 19 quarters.
- Edge Capital Group's Bristol-Myers Squibb position peaked at $1.55M in Q1 2023.
- 2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.
Based on Edge Capital Group's 13F filing for Q4 2023, filed 13 Feb 2024.